Insight

C. Ola Landgren: How Quadruplet Therapy Is Changing the Myeloma Treatment Landscape

Photo taken from C. Ola Landgren/X

Jun 22, 2024, 04:41

C. Ola Landgren: How Quadruplet Therapy Is Changing the Myeloma Treatment Landscape

C. Ola Landgren, Chief of the Division of Myeloma at University of Miami and Leader of Experimental Therapeutics Program at Sylvester Comprehensive Cancer Center, shared a post on X:

“How Quadruplet Therapy Is Changing the Myeloma Treatment Landscape.

Summary of Latest News From ASCO24 Focusing on Newly Diagnosed Myeloma Therapy.

Watch here.”

Source: C. Ola Landgren/X

American Society for Clinical Oncology ASCO24 C. Ola Landgren cancer Myeloma myeloma treatment OncoDaily Oncology Quadruplet Therapy Sylvester Comprehensive Cancer Center

Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity